Related Experiment Video
Updated: Dec 20, 2025

11:17
Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor
Published on: February 10, 2014
12.0K
Harnessing Selectivity and Sensitivity in Electronic Biosensing: A Novel Lab-on-Chip Multigate Organic Transistor
Vitaliy Parkula1,2, Marcello Berto1, Chiara Diacci1,3
1Dipartimento di Scienze della Vita, Università degli Studi di Modena e Reggio Emilia, Via Campi 103, 41125 Modena, Italy.
Analytical Chemistry
|June 3, 2020
Summary
This study introduces a novel organic electronic lab-on-chip device for ultrasensitive biosensing. The device accurately detects tumor necrosis factor alpha at low concentrations, paving the way for improved point-of-care diagnostics.
Area of Science:
- Organic electronics
- Biosensing technology
- Lab-on-a-chip devices
Background:
- Electrolyte-gated organic transistors (EGOFETs) show promise as ultrasensitive biosensors.
- Reducing nonspecific interactions is crucial for enhancing selectivity in biosensing.
- Accurate detection of inflammatory cytokines like TNFα is vital for disease monitoring.
Purpose of the Study:
- To develop a novel lab-on-a-chip device integrating a multigate EGOFET for enhanced biosensing.
- To assess the reproducibility and selectivity of the EGOFET sensing platform.
- To demonstrate the device's capability for quantifying specific biomarkers.
Main Methods:
- Integration of a multigate electrolyte-gated organic field-effect transistor (EGOFET) with a microfluidics setup.
- Utilizing an internal reference electrode to evaluate device selectivity.
- Performing triplicate measurements to ensure response reproducibility.
Main Results:
- Demonstrated efficient operation of a pentacene-based EGOFET sensing platform.
- Achieved quantification of tumor necrosis factor alpha (TNFα) with a detection limit as low as 3 pM.
- Confirmed statistically solid, reliable, and selective responses on microliter sample volumes within minutes.
Conclusions:
- The developed multiplexable organic electronic lab-on-chip offers a robust platform for sensitive and selective biomarker detection.
- The device meets key performance indicators for point-of-care diagnostics, enabling rapid analysis of small sample volumes.
- This technology has significant potential for monitoring inflammatory cytokines and aiding in disease diagnosis.

